What Is Peptide Therapy?

Peptide Therapy Defined

What is a peptide?

A peptide is a short chain of amino acids — typically 2 to 50 — linked by peptide bonds. Below 50 amino acids, a chain is a peptide; above that, it is a protein. Natural examples include insulin (technically a small protein at 51 amino acids), oxytocin (9), and glucagon (29).

In therapeutic contexts, peptides are synthesized pharmaceutically to replicate or analog a naturally occurring signaling molecule. Because most peptides interact with specific cellular receptors, they tend to produce more narrowly targeted effects than small-molecule drugs that may bind multiple targets.

How peptides signal the body

Peptides work primarily by binding to cell-surface receptors, triggering downstream cascades that modulate gene expression, protein synthesis, or secretion of other hormones. Examples:

• Sermorelin binds the GHRH receptor on the pituitary, stimulating endogenous growth hormone release.
• Semaglutide binds the GLP-1 receptor, slowing gastric emptying and improving insulin sensitivity.
• BPC-157 is thought to modulate nitric oxide signaling and growth factor pathways at sites of tissue damage.

Because they rely on existing receptor networks, peptides can often be dosed in ways that preserve the body's own feedback regulation — a key distinction from direct hormone replacement.

Therapeutic vs. performance vs. research peptides

Three categories dominate the conversation:

• Therapeutic peptides — FDA-approved or compounded for specific clinical indications, prescribed by a licensed clinician.
• Performance peptides — prescribed (or self-sourced) for athletic and physique outcomes; regulatory status varies.
• Research peptides — sold explicitly “for research use only,” not for human consumption; this market is unregulated and frequently cited as a source of contamination and mislabeling.

The Peptide Association works only with providers and pharmacies operating within the therapeutic category.

How Peptide Therapy Works

Receptor binding and biological cascades

When a peptide binds its target receptor, it triggers a specific cascade — often involving G-protein coupled signaling, enzyme activation, or ion channel modulation. This is why peptide therapy can produce highly targeted effects: a compound designed for the growth hormone axis will not, generally, affect the reproductive axis, and vice versa.

Administration routes

Most therapeutic peptides are administered via:

• Subcutaneous injection (most common) — reliable absorption, patient-administered after training.
• Intramuscular injection — used for specific protocols.
• Intranasal spray — for compounds like PT-141 or oxytocin.
• Oral — limited bioavailability for most peptides; exceptions exist (e.g., BPC-157 for GI indications).
• Transdermal — emerging formulations, indication-specific.

Route matters because peptides are typically degraded in the digestive tract — which is why oral administration is not the default for systemic peptide effects.

Why peptides are typically prescribed by a physician

Dosing, cycling, route selection, compound combination, and monitoring all require clinical judgment. Self-administering peptides from research-chemical sources is associated with contamination, mislabeling, and dosing errors. A credentialed clinician provides the workup, sourcing oversight, and ongoing lab monitoring that makes therapy safe and trackable.

Common Peptides Used in Therapy

BPC-157 — tissue repair, gut health

Body Protection Compound 157, derived from a protective sequence in human gastric juice. Commonly used for tendinopathy, ligamentous injury, and gastrointestinal inflammation. See the BPC-157 clinician's guide for a full breakdown.

Sermorelin — growth hormone secretagogue

A 29-amino-acid fragment of GHRH that stimulates endogenous growth hormone release. Often used for age-related GH decline, sleep optimization, and body composition protocols. See sermorelin peptide therapy.

Semaglutide and tirzepatide — metabolic, GLP-1

FDA-approved GLP-1 receptor agonists (semaglutide as Wegovy/Ozempic, tirzepatide as Zepbound/Mounjaro). Widely used for type 2 diabetes and chronic weight management.

CJC-1295 / Ipamorelin — growth hormone axis

Often stacked with sermorelin or each other. CJC-1295 extends GH release duration, while ipamorelin provides a cleaner receptor-specific pulse.

PT-141 (Bremelanotide) — sexual health

A melanocortin receptor agonist used for sexual dysfunction in both men and women.

Thymosin alpha-1 — immune modulation

Under investigation for immune support in chronic infection and autoimmune contexts.

Browse the full peptide database for research summaries, dosing references, and regulatory notes on every tracked compound.

Conditions Peptide Therapy Is Being Used For

Tissue repair and injury recovery

BPC-157, TB-500, and thymosin beta-4 are commonly protocoled for tendinopathy, ligamentous injury, and post-surgical recovery.

Metabolic health and weight management

GLP-1 agonists have fundamentally changed the metabolic medicine landscape and are increasingly integrated with other peptides in protocolized care.

Age-related decline (hormone optimization)

Growth hormone secretagogues and, where appropriate, co-therapy with TRT or HRT, target somatopause — the age-related decline in GH secretion that correlates with changes in body composition, sleep, and recovery.

Immune dysregulation

Thymosin alpha-1 and related compounds are studied in chronic viral infection, autoimmunity-adjacent conditions, and post-viral syndromes.

Neurocognitive support

Dihexa, cerebrolysin, and selank are investigated for cognition, though evidence quality varies significantly by compound.

What peptide therapy is NOT

Peptide therapy is not a universal solution. It does not replace primary care, it does not cure disease in most cases, and it cannot compensate for undiagnosed underlying conditions. A good peptide protocol works within a broader framework of labs, lifestyle, and conventional medicine.

Is Peptide Therapy Safe?

The importance of sourcing from a compounding pharmacy

The single biggest safety variable in peptide therapy is the source. 503A compounding pharmacies operate under state board of pharmacy oversight and fill patient-specific prescriptions. 503B outsourcing facilities meet additional FDA cGMP requirements and can compound in larger batches. Both are legitimate channels — the Peptide Association supplier network verifies sourcing for every directory provider.

Why provider credentials matter

Credentialed clinicians bring three things non-credentialed providers cannot: appropriate workup, individualized dosing, and ongoing monitoring. The cost difference between a vetted provider and a discount telehealth operation is often smaller than patients assume — and the risk profile is dramatically different.

Common side effects and contraindications

Most peptides have favorable safety profiles at therapeutic doses, but adverse events do occur — injection site reactions, headache, altered glucose metabolism (particularly with GH-axis peptides), and compound-specific contraindications. Active malignancy, pregnancy, and certain cardiovascular conditions are common exclusions.

Red flags when choosing a provider

• No labs before starting therapy
• Sourcing that is vague, offshore, or described as “research grade”
• Pressure to commit to long-term contracts before a workup
• No ongoing follow-up built into the program
• One-size-fits-all dosing regardless of patient

Regulatory Status in the United States

FDA framework for peptides

Peptides occupy a complex regulatory position. Some — like semaglutide and tirzepatide — are FDA-approved finished drug products. Others are accessed exclusively through 503A compounding pharmacies under licensed prescribers. A handful have been specifically restricted or placed on the FDA Bulks List with conditions.

Compounding pharmacy oversight

503A pharmacies are overseen by state boards of pharmacy and the federal compounding law (DQSA). 503B facilities face additional FDA oversight and cGMP compliance requirements. Legitimate peptide therapy always routes through one of these two channels.

Recent 2026 regulatory updates

The regulatory landscape shifts regularly. See the Peptide Association regulatory tracker for current status of individual compounds and state-level rule changes.

What Peptide Therapy Costs

Typical cost ranges per compound

Monthly costs for common protocols:

• Tissue-repair peptides (BPC-157, TB-500): $150–$400/month
• Growth hormone secretagogues (sermorelin, CJC/Ipamorelin): $200–$500/month
• GLP-1 agonists: varies significantly; branded products are $500–$1,300/month cash-pay, compounded versions lower
• PT-141: $150–$300/month
• Comprehensive protocols with multiple compounds: $500–$1,500/month

Insurance considerations

Most peptides are not covered by commercial insurance outside of approved indications. GLP-1 agonists may be covered for type 2 diabetes; specific formulations may have coverage paths for other conditions. Assume cash-pay for initial consultation and most ongoing therapy.

Cash-pay vs. concierge care models

Peptide clinics fall along a spectrum from pay-per-visit discount telehealth (low cost, limited monitoring) to concierge care that bundles labs, peptides, and provider access for a flat monthly fee. Fit depends on how much ongoing coordination a patient wants.

How to Start Peptide Therapy